Paper39587209
Orally delivered biodegradable targeted inflammation resolving pectin-coated nanoparticles induce anastomotic healing post intestinal surgery.
Lee JH and 11 others. Sci Rep, 2024. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. Orally delivered biodegradable targeted inflammation resolving pectin-coated nanoparticles induce anastomotic healing post intestinal surgery. Papers, record 39587209. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39587209
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Orally delivered biodegradable targeted inflammation resolving pectin-coated nanoparticles induce anastomotic healing post intestinal surgery.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Pectins | Major topic |
| Nanoparticles | Major topic |
| Wound Healing | Major topic |
| Animals | |
| Mice | |
| Anastomosis, Surgical | |
| Administration, Oral | |
| Disease Models, Animal | |
| Inflammation | |
| Colitis | |
| Drug Delivery Systems | |
| Chitosan | |
| Male | |
| Inflammatory Bowel Diseases | |
| Humans | |
| Mice, Inbred C57BL |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R215-2015-4190 | Lundbeck Foundation | PubMed | ||
| R215-2015-4190 | Lundbeck Foundation | PubMed | ||
| 1834/2-1 | Deutsche Forschungsgemeinschaft | PubMed | ||
| 1834/2-1 | Deutsche Forschungsgemeinschaft | PubMed |
Source PubMed
References32
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22914295 | Crohn's disease. | Lancet | 2012 | https://conductscience.org/library/papers/22914295 | PubMed |
| 2 | 22914296 | Ulcerative colitis. | Lancet | 2012 | https://conductscience.org/library/papers/22914296 | PubMed |
| 3 | 29998389 | NSAID administration post colorectal surgery increases anastomotic leak rate: systematic review/meta-analysis. | Surg Endosc | 2019 | https://conductscience.org/library/papers/29998389 | PubMed |
| 4 | 24899309 | Pro-resolving lipid mediators are leads for resolution physiology. | Nature | 2014 | https://conductscience.org/library/papers/24899309 | PubMed |
| 5 | 23583354 | Resolution of inflammation: mechanisms and opportunity for drug development. | Pharmacol Ther | 2013 | https://conductscience.org/library/papers/23583354 | PubMed |
| 6 | 19845684 | Exploiting the Annexin A1 pathway for the development of novel anti-inflammatory therapeutics. | Br J Pharmacol | 2009 | https://conductscience.org/library/papers/19845684 | PubMed |
| 7 | 19104500 | Annexin A1 and glucocorticoids as effectors of the resolution of inflammation. | Nat Rev Immunol | 2009 | https://conductscience.org/library/papers/19104500 | PubMed |
| 8 | 20215502 | Annexin 1 induced by anti-inflammatory drugs binds to NF-kappaB and inhibits its activation: anticancer effects in vitro and in vivo. | Cancer Res | 2010 | https://conductscience.org/library/papers/20215502 | PubMed |
| 9 | 15920146 | Critical protective role for annexin 1 gene expression in the endotoxemic murine microcirculation. | Am J Pathol | 2005 | https://conductscience.org/library/papers/15920146 | PubMed |
| 10 | 16547279 | Spatial and temporal profiles for anti-inflammatory gene expression in leukocytes during a resolving model of peritonitis. | J Immunol | 2006 | https://conductscience.org/library/papers/16547279 | PubMed |
| 11 | 15022342 | Modulation of inflammation and response to dexamethasone by Annexin 1 in antigen-induced arthritis. | Arthritis Rheum | 2004 | https://conductscience.org/library/papers/15022342 | PubMed |
| 12 | 23241962 | Annexin A1, formyl peptide receptor, and NOX1 orchestrate epithelial repair. | J Clin Invest | 2013 | https://conductscience.org/library/papers/23241962 | PubMed |
| 13 | 11641252 | Annexin 1 peptides protect against experimental myocardial ischemia-reperfusion: analysis of their mechanism of action. | FASEB J | 2001 | https://conductscience.org/library/papers/11641252 | PubMed |
| 14 | 9792213 | Lipocortin 1 and chemokine modulation of granulocyte and monocyte accumulation in experimental inflammation. | Gen Pharmacol | 1998 | https://conductscience.org/library/papers/9792213 | PubMed |
| 15 | 12368905 | Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor. | Nat Med | 2002 | https://conductscience.org/library/papers/12368905 | PubMed |
| 16 | 22388185 | Targeted polymeric therapeutic nanoparticles: design, development and clinical translation. | Chem Soc Rev | 2012 | https://conductscience.org/library/papers/22388185 | PubMed |
| 17 | 26854975 | Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release. | Chem Rev | 2016 | https://conductscience.org/library/papers/26854975 | PubMed |
| 18 | 25695999 | Targeted nanoparticles containing the proresolving peptide Ac2-26 protect against advanced atherosclerosis in hypercholesterolemic mice. | Sci Transl Med | 2015 | https://conductscience.org/library/papers/25695999 | PubMed |
| 19 | 21692448 | Self-assembled targeted nanoparticles: evolution of technologies and bench to bedside translation. | Acc Chem Res | 2011 | https://conductscience.org/library/papers/21692448 | PubMed |
| 20 | 17070960 | Nanomedicine: developing smarter therapeutic and diagnostic modalities. | Adv Drug Deliv Rev | 2006 | https://conductscience.org/library/papers/17070960 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42807536 | Microenvironment-Responsive Nanomaterials for Colorectal Anastomotic Healing: A Signal-Threshold-Response Framework for Stage-Adaptive Repair. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42807536 | PubMed |
| 42518473 | Light-Triggered and Sustained Delivery of Dexamethasone Using Chitosan-Coated PLGA Nanoparticles for Posterior Eye Disease Treatment. | ACS Omega | 2026 | https://conductscience.org/library/papers/42518473 | PubMed |
| 42196488 | Macrophages in Intestinal Wound Healing: Dichotomous Effects and Therapeutic Opportunities. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42196488 | PubMed |
| 41892571 | Next-Generation Hydrogels Integrating Natural Antioxidants and Microbiome Modulators for Improved Cancer Management. | Gels | 2026 | https://conductscience.org/library/papers/41892571 | PubMed |
| 41080582 | Systemic dysregulation of the gut microenvironment plays a pivotal role in the onset and progression of inflammatory bowel disease. | Front Immunol | 2025 | https://conductscience.org/library/papers/41080582 | PubMed |
| 40686644 | Peptide-based therapeutic and delivery strategies for inflammatory bowel disease: challenges and future directions. | RSC Adv | 2025 | https://conductscience.org/library/papers/40686644 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39587209
GET https://conductscience.org/api/papers/v1/39587209/references?page=2